Results 21 to 30 of about 641 (87)

Oncolytic Therapy: Delivery System and New Therapeutic Strategies for Cancer

MedComm, Volume 7, Issue 4, April 2026.
This review summarizes recent advances in nanoparticle‐ and cell‐mediated OVs delivery strategies that improve biodistribution and tumor targeting while limiting immune clearance. It also examines combination approaches that enhance therapeutic efficacy through tumor microenvironment modulation or immune activation, thereby overcoming immunosuppression
Sikan Jin, Yi Zhang, Ziling Zhou, Yaqi Zhang, Ting Yu, Rui Xu, Lin Xu, Jidong Zhang, Longze Zhang, Shan Yang, Xianyao Wang   +10 more
wiley   +1 more source

Malignant Rhabdoid Tumors of the Liver Are Associated With Inferior Outcomes Compared to Other Extracranial Rhabdoid Tumors

Pediatric Blood &Cancer, Volume 72, Issue 12, December 2025.
ABSTRACT Background Extracranial malignant rhabdoid tumors (eMRT) are rare, highly aggressive pediatric neoplasms. While the liver is a relatively common anatomic site of presentation, the clinical course of patients with hepatic eMRT (eMRT‐L) is not well described.
Sebastian Bühner, Katharina Gastberger, Stefanie Tüchert‐Knoll, Victoria E. Fincke, Pascal D. Johann, Patrick Melchior, Margarita Teleshova, Denis Kachanov, Alexey Shcherbakov, Irene Schmid, Kleoniki Roka, Reiner Siebert, Christian Vokuhl, Joachim Gerss, Jörg Fuchs, Rhoikos Furtwängler, Michael C. Frühwald   +16 more
wiley   +1 more source

Multimodal management and outcome of pediatric and adolescent malignant central nervous system tumors: A single‐center retrospective study

Malignancy Spectrum, Volume 2, Issue 3, Page 128-139, September 2025.
Abstract Objective There is a paucity of real‐world evidence in the Indian context to address the outcome of primary brain tumors (PBTs) in children. This study aimed to describe the demographic profile, clinical characteristics, and histological features of PBTs based on the 2016 World Health Organization classification, assess the efficacy of ...
Priyadharshini Veeralakshmanan, Wesley M. Jose, Suhas Udayakumaran, M. R. Bindhu, Debnarayan Dutta, Kannan Rajesh, Sruthi Kavalagunta, Renjitha Bhaskaran, Nikhil K. Haridas, M. P. Rakesh, Keechilat Pavithran   +10 more
wiley   +1 more source

Congenital Intracranial Tumors: Prenatal Diagnosis by Fetal Magnetic Resonance Imaging

iRADIOLOGY, Volume 3, Issue 3, Page 203-208, June 2025.
Fetal intracranial tumors are rare, comprising 0.5%–1.9% of all childhood tumors, with their true incidence potentially underestimated. This review highlights the role of fetal MRI, particularly with advanced sequences, in diagnosing common fetal brain tumors such as teratomas, astrocytomas, and choroid plexus papillomas, often presenting unique ...
Jing‐Ya Ren, Hui Ji, Ming Zhu, Su‐Zhen Dong   +3 more
wiley   +1 more source

Inhibition of the NLRP3 inflammasome using MCC950 reduces vincristine‐induced adverse effects in an acute lymphoblastic leukemia patient‐derived xenograft model

HemaSphere, Volume 9, Issue 3, March 2025.
Abstract Vincristine is one of the most important chemotherapeutic drugs used to treat acute lymphoblastic leukemia (ALL). Unfortunately, vincristine often causes severe adverse effects, including sensory–motor neuropathies, weight loss, and overall decreased well‐being, that are difficult to control and that decrease the quality of life and survival ...
Hana Starobova, Hannah McCalmont, Svetlana Shatunova, Nicolette Tay, Christopher M. Smith, Avril Robertson, Ingrid Winkler, Richard B. Lock, Irina Vetter   +8 more
wiley   +1 more source

Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome

American Journal of Medical Genetics Part C: Seminars in Medical Genetics, Volume 196, Issue 4, December 2024.
Abstract Neurofibromatosis type 1 (NF‐1) microdeletion syndrome accounts for 5 to 11% of individuals with NF‐1. The aim of our study was to characterize a large cohort of individuals with NF‐1 microdeletion syndrome and expand its natural history.
Jenny P. Garzon, Andrea Patete, Lindsey Aschbacher‐Smith, Dima Qu'd, Geraldine Kelly‐Mancuso, Carolyn R. Raski, Allison Goetsch Weisman, Madison Hankins, Michael Sawin, Katherine Kim, Andy Drackley, Janice Zeid, K. Nicole Weaver, Robert J. Hopkin, Howard M. Saal, Joel Charrow, Elizabeth Schorry, Robert Listernick, Brittany N. Simpson, Carlos E. Prada   +19 more
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Abstracts

Molecular Oncology, Volume 19, Issue S1, Page 1-940, June 2025.
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

ISEV2025 Abstract Book

Journal of Extracellular Vesicles, Volume 14, Issue S1, October 2025.
wiley   +1 more source

Hemispherotomy for atypical teratoid rhabdoid tumor-associated drug-resistant epilepsy: illustrative case. [PDF]

J Neurosurg Case Lessons
Hect JL, Ong J, Felker J, Welch W, Greene S, Abel TJ.   +5 more
europepmc   +1 more source